deoxycytidine and Incontinentia Pigmenti Achromians

deoxycytidine has been researched along with Incontinentia Pigmenti Achromians in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alonso, V; Calduch, L; Jordá, E; Martín, JM; Pinazo, MI; Villalón, G1
Hymes, SR; Paravar, T1
Ajisawa, A; Fukutake, K; Kato, Y; Nakamura, T; Negishi, M; Odawara, T; Shirasaka, T; Tadokoro, T; Yamamoto, Y1

Trials

1 trial(s) available for deoxycytidine and Incontinentia Pigmenti Achromians

ArticleYear
Investigation of emtricitabine-associated skin pigmentation and safety in HIV-1-infected Japanese patients.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Anti-HIV Agents; Deoxycytidine; Dermoscopy; Emtricitabine; Female; Hand; HIV Infections; Humans; Incidence; Japan; Lentigo; Male; Middle Aged; Pigmentation Disorders; Prospective Studies; Skin; Skin Pigmentation; Viral Load

2011

Other Studies

3 other study(ies) available for deoxycytidine and Incontinentia Pigmenti Achromians

ArticleYear
Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
    American journal of clinical dermatology, 2009, Volume: 10, Issue:4

    Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Dermoscopy; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Middle Aged; Pigmentation Disorders; Tongue Diseases

2009
Longitudinal melanonychia induced by capecitabine.
    Dermatology online journal, 2009, Oct-15, Volume: 15, Issue:10

    Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Nail Diseases; Pigmentation Disorders

2009
Skin discoloration with FTC.
    AIDS patient care and STDs, 2004, Volume: 18, Issue:10

    Topics: Clinical Trials, Phase III as Topic; Deoxycytidine; Emtricitabine; Humans; Pigmentation Disorders

2004